Wearable defibrillator

Journal of Cardiovascular Nursing

Volumn 16, Issue 3, 2002, Pages 44-52

  Schott, Roseanne ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Defibrillators; Sudden cardiac death; Ventricular fibrillation; Wearable defibrillator

Indexed keywords

CARDIOVERSION; EQUIPMENT DESIGN; HEART ARRHYTHMIA; HUMAN; INSTRUMENTATION; PATHOPHYSIOLOGY; REVIEW; SUDDEN DEATH;

ARRHYTHMIA; DEATH, SUDDEN, CARDIAC; ELECTRIC COUNTERSHOCK; EQUIPMENT DESIGN; HUMANS;

EID: 0036550190     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/00005082-200204000-00006     Document Type: Article

References (20)

1. Doherty JU, Fuchs S, Tecce MA. Ventricular arrhythmias. Preventing sudden death with drugs and ICD devices. Geriatrics. 2000;55:26-8, 31-32, 35-36.
2. Davies MJ. The investigation of sudden cardiac death. Histopathology. 1999;34:93-98.
3. Chugh SS, Kelly DL, Titus JL. Sudden cardiac death with apparently normal heart. Circulation. 2000;102:649-654.
4. Singh SN, Fletcher RD. Class III drugs and congestive heart failure: focus on the congestive heart failure-survival trial of antiarrhythmic therapy. Am J Cardiol. 1999;84:103R-108R.
5. Wyse DG, Greene HL. Indications for implantable cardioverter defibrillators: Clinical trials. In: Clinical Cardiac Pacing and Defibrillation. Philadelphia, Pa: Saunders;2000.
6. Goldberger JJ. Treatment and prevention of sudden cardiac death: effect of recent clinical trials. Arch Intern Med. 1999;159:1281-1287.
7. Zivin A, Bardy GH. Implantable defibrillators and antiarrhythmic drugs in patients at risk for lethal arrhythmias. Am J Cardiol. 1999;84:63R-68R.
8. Kastor JA. Michel Mirowski and the automatic implantable defibrillator. Am J Cardiol. 1989;63:1121-1126.
9. Rosenqvist M, Beyer T, Block M, Dulk K, Minten J, Lindemans F. Adverse event with transvenous implantable cardioverter-defibrillators. A prospective multicenter study. Circulation. 1998;98:663-670.
10. Pinski S. Emergencies related to implantable cardioverter-defibrillators. Crit Care Med. 2000;28:N174-N180.
11. Kron J, Herre J, Renfroe E, et al. Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial. Am Heart J. 2001;141:192-198.
12. Singer I. Evaluation of implantable cardioverter-defibrillator malfunction, diagnostics, and programmers. In: Clinical Cardiac Pacing and Defibrillation. Philadelphia, Pa: Saunders;2000.
13. Kern KB. Public access defibrillation: a review. Heart. 1998;80:402-404.
14. Sweeney TA, Runge JW, Gibbs MA, et al. EMT defibrillation does not increase survival from sudden cardiac death in a two-tiered urban-suburban EMS system. Ann Emerg Med. 1998;31:234-240.
15. Heilman MS, Szymkiewicz SJ. WCD System Premarket Approval Investigational Plan, Document Number 90D0019 1997. Philadelphia, Pa: LifeCor, Inc.
16. Wood M, Serdlow C, Olson W. Sensing and arrhythmia detection by implantable devices. In: Clinical Cardiac Pacing and Defibrillation. Philadelphia, Pa: Saunders;2000.
17. Auricchio A, Klein H, Geller CJ, Reek S, Heilman MS, Szymkiewicz SJ. Clinical efficacy of the Wearable Cardioverter-Defibrillator in acutely terminating episodes of ventricular fibrillation. Am J Cardiol. 1998;81:1253-1256.
18. Meltendorf U, Wollbrueck A, Auricchio A, Rook S, Geller C, Klein H. The wearable defibrillator-a new method to prevent sudden death. Pace. 2000;23(pt II):806.
19. Ahmad M, Bloomstein L, Roelke M, Berstein A, Parsonnet V. Patients' attitudes toward implantable defibrillator shocks. Pace. 2000;23:934-938.
20. Stump GL, Wallace AA, Gilberto DB, Gehret JR, Lynch JJ. Arrhythmogenic potential of positive inotropic agents. Basic Res Cardiol. 2000;95:186-198.